Company

Marinus Pharmaceuticals, Inc.

Headquarters: Radnor, PA, United States

Employees: 100

CEO: Dr. Scott N. Braunstein M.D.

NASDAQ: MRNS -3.77%

Market Cap

$65.9 Million

USD as of July 1, 2024

Market Cap History

Marinus Pharmaceuticals, Inc. market capitalization over time

Evolution of Marinus Pharmaceuticals, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Marinus Pharmaceuticals, Inc.

Detailed Description

Marinus Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing and commercializing therapeutics to treat rare seizure disorders. Its clinical stage product candidate, ganaxolone, is an allosteric modulator of GABAA, developed in formulations for two routes, including intravenous (IV) and oral for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ganaxolone product candidate, acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for status epilepticus, cyclin dependent kinase like 5 deficiency disorder, PCDH19-related epilepsy, tuberous sclerosis complex, and postpartum depression. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Marinus Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: NASDAQ: MRNS wb_incandescent

Stock: BMV: MRNS wb_incandescent

Stock: FSX: 61Y wb_incandescent

Details

Headquarters:

5 Radnor Corporate Center

Suite 500 100 Matsonford Road

Radnor, PA 19087

United States

Phone: 484 801 4670